FDA Investigator Zachary Ryan Harris
Zachary Ryan Harris has conducted inspections on 54 sites in 1 countries as of 08 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
54
Last Inspection Date:
08 Jul 2024
Investigator Role:
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Zachary Ryan Harris:
Aimee K Contreras,
Alex G Kalugin,
Angela D Wise,
Brian R Henderson,
Carla J Lundi,
Cathleen A Carr Sharpe,
Celena Ngo,
Christina D Mello,
Christopher J Lee,
Creighton T Tuzon,
Cristina Resendiz Navarrete,
Daniel J Roberts,
Davis,
Dena L Jacobs,
Doan T Nguyen, PharmD,
Dyana K Stone,
Edna J Hidalgo,
Eric J Heinze,
Estefania Fernandez,
Francisco,
Garciam,
Geoffrey M Leist,
Grace P Santos,
Grant M Ruis,
Haejung An,
Helen J Hamaoka,
Huy T Pham,
Ismael Garibay,
James A Barreto,
James C Yee,
Janice M Loy,
Janice R Small,
Jazmine M Welcher,
Jeff M Uriarte,
Jennifer S King,
Jeremy H Nguyen,
Jessica B Darneille,
Jinnie Kokiatkulkij,
John C Su,
Jonathan K Dare,
Jorge L Bertran,
Joseph C Yen,
Joseph M Willems,
Juan A Morales,
Judy C Nepsa,
Karen J Bak,
Keren Arkin,
Kevin Lee,
Kevin N Tran,
Kevin T Gerrity,
Kimberly M Lichter,
Kin T Moy,
Lea Lakes,
Lija V Fellows,
Lisa H Nakagawa,
Lorenzo F Edwards,
Macropolk,
Mark E Baldwin,
Marlo Ianm Alintanahin,
Matthew A Walburger,
Megan E Kulas,
Michael D Garcia,
Michael S Call,
Michele R Douglas,
Michelle L Tripp,
Ngoc T Le,
Nianna C Burns,
Patricia F Alberico,
Phal K Chhun,
Phillip L Toy,
Phung,
Rachel V Leimbach,
Robert C Hoover,
Robert J Waldorf,
Rochelle A Rolnik,
Romero,
Ruben G Abrajano,
Russell R La Claire,
Sara Jdent Acosta,
Scott K Zika,
Sean P Desbrow,
Sparky L Bartee,
Steven M Galvez,
Stuart W Russell,
Sundy V Sedwick,
Susanna N Choi,
Tanya E Malais,
Terrance L Thomas,
Thao T Kwan,
Thomas N Adjabeng,
Timothy P Lafave,
Travelle D Mason,
Trushani T Desai,
Wayne L Jefferson,
Yen Tso Kuo,
Yvonne T Lacour
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more